Enanta Pharmaceuticals, Inc. (ENTA) NASDAQ
12.03
-0.64(-5.05%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
12.03
-0.64(-5.05%)
Currency In USD
| Market Cap | 255.39M |
| Enterprise Value | 424.15M |
| P/E Ratio | -5.61 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 4.04 |
| Price/Book Ratio | 2.98 |
| Enterprise/Revenue | 6.23 |
| Enterprise/EBITDA | -8.86 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.9 |
| Operating Margin | -0.87 |
| Return On Assets | -0.2 |
| Return On Equity | -0.64 |
| Revenue | 65.32M |
| Revenue/Share | 2.4 |
| Gross Profit | 60.74M |
| EBITDA | -70.78M |
| Net Income | -81.89M |
| Diluted EPS | -3.84 |
| Total Cash | 163.77M |
| Total Cash/Share | 5.67 |
| Total Debt | 186.62M |
| Total Debt/Equity | 1.6 |
| Current Ratio | 3.84 |
| Book Value Per Share | 4.04 |
| 52-Week Change | 91.26 |
| 52-Week High | 17.15 |
| 52-Week Low | 6.44 |
| Moving Average 50 Days | 13.63 |
| Moving Average 200 Days | 12.51 |
| Average Volume | 169,253 |
| Shares Outstanding | 23.22M |
| % Held by Institutions | 125.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |